CLINICAL_TRIALS ClinicalTrials.gov record with results posted

Phase Ib/II Study of ALT-801 With Cisplatin in Patients With Metastatic Melanoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01029873
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-09-11T00:01:08.995504+00:00
Published At: 2026-09-10T00:00:00+00:00
Record Updated At: 2026-09-10
Results Posted At: 2026-09-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Metastatic Melanoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-09-10"
protocolSection.identificationModule.nctId: "NCT01029873"
protocolSection.identificationModule.officialTitle: "Phase Ib/II Study of ALT-801 With Cisplatin in Patients With Metastatic Melanoma"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-09-10"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.